Vivalacara Dermalere Advanced Skin Cream

The dosage of Calendula Officinalis Flower varies significantly based on the indication and the route of administration. For topical applications in wound healing or dermatitis, a cream or ointment containing 2-5% Calendula extract is typically applied to the affected area 2 to 4 times daily. It is important to clean the area thoroughly before application to ensure maximum absorption and prevent secondary infections.

For oral administration (e.g., in capsules or tablets), the standard adult dose ranges from 300 mg to 600 mg, taken two to three times daily. When used as a liquid tincture (1:5 in 40% alcohol), a common dose is 1-2 mL three times a day. If being used for allergen desensitization under the Standardized Insect Venom Allergenic Extract [EPC] protocol, the dosage is highly individualized and determined by an allergist through a series of escalating subcutaneous injections.

Calendula Officinalis Flower should be used with caution in pediatric populations. For children aged 6 to 12 years, topical application is generally considered safe when used sparingly on small areas of the skin. Oral dosing for children is not well-established, and many clinicians recommend avoiding internal use in patients under the age of 12 unless specifically directed by a pediatrician. For infants and toddlers (under 6 years), use is typically restricted to very low-concentration topical preparations for diaper rash, and only under medical supervision.

Renal Impairment

Because a significant portion of Calendula metabolites are excreted via the kidneys, patients with moderate to severe renal impairment (CrCl < 30 mL/min) may require a dose reduction of 25-50% for oral formulations to prevent systemic accumulation. Topical use generally does not require adjustment unless applied to very large surface areas.

Hepatic Impairment

In patients with hepatic dysfunction, the metabolism of triterpenoids may be slowed. While no specific guidelines exist, healthcare providers should monitor liver function tests (LFTs) if high-dose oral therapy is maintained for more than two weeks.

Elderly Patients

Geriatric patients often have thinner skin and reduced renal clearance. For topical use, a lower frequency of application may be sufficient. For oral use, clinicians should start at the lowest end of the dosing spectrum (e.g., 300 mg once daily) and titrate upward based on tolerance.

• Topical: Apply a thin layer to the affected area. Do not cover with occlusive (air-tight) dressings unless instructed by a doctor, as this can increase systemic absorption excessively.
• Oral: Take with a full glass of water. Taking Calendula with a meal containing some healthy fats (like olive oil or avocado) may improve the absorption of its fat-soluble components.
• Storage: Store all formulations at room temperature (15°C to 30°C or 59°F to 86°F). Keep away from direct sunlight and moisture, as light can degrade the carotenoid content.

If you miss a dose of Calendula Officinalis Flower, take or apply it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and resume your regular schedule. Do not double the dose to catch up, as this increases the risk of localized irritation or systemic side effects.

Signs of a topical overdose include severe skin redness, burning, or the development of a rash (contact dermatitis). Oral overdose may manifest as nausea, vomiting, or mild dizziness. In the event of an accidental ingestion of a large quantity of topical ointment, contact your local poison control center or seek emergency medical attention immediately. While Calendula is generally low in toxicity, the base ingredients in creams (like petroleum or alcohols) can cause complications if ingested.

> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose or stop treatment without medical guidance, especially if using Calendula for immunological desensitization.

Most patients tolerate Calendula Officinalis Flower well, especially when used topically. However, common side effects can occur, particularly in those with sensitive skin. These may include:

• Mild Skin Irritation: A slight tingling or warming sensation upon application.
• Dryness: Some alcohol-based tinctures or gels may cause localized skin dryness or flaking over time.
• Erythema: Temporary redness at the site of application, which usually subsides within an hour.

• Contact Dermatitis: A more pronounced itchy rash or small bumps at the application site. This is more common in individuals who are already sensitive to other plants in the Asteraceae family (like ragweed or daisies).
• Photosensitivity: Increased sensitivity to sunlight in the area where the product was applied, potentially leading to a faster sunburn.
• Nausea: When taken orally, some patients report mild gastrointestinal upset or a bitter aftertaste.

• Anaphylaxis: A severe, life-threatening allergic reaction. Symptoms include swelling of the face or throat, difficulty breathing, and a rapid drop in blood pressure.
• Hepatotoxicity: Very rare cases of elevated liver enzymes have been noted with extremely high-dose, long-term oral supplementation.
• Tachycardia: An abnormally fast heart rate, which may be related to the l-Thyroxine [EPC] classification and its potential metabolic effects.

> Warning: Stop taking Calendula Officinalis Flower and call your doctor immediately if you experience any of these serious symptoms:

• Severe Allergic Reaction: Hives, swelling of the lips, tongue, or throat, or any difficulty breathing (signs of angioedema or anaphylaxis).
• Extensive Skin Peeling: Large areas of skin sloughing off or blistering (signs of Stevens-Johnson Syndrome, though extremely rare for this ingredient).
• Jaundice: Yellowing of the eyes or skin, dark urine, or severe upper abdominal pain.
• Chest Pain or Palpitations: Feeling like your heart is racing, skipping beats, or fluttering.
• Significant Dizziness or Fainting: This could indicate a systemic reaction or a drop in blood pressure.

Prolonged use of Calendula Officinalis Flower (exceeding 3-6 months of continuous use) has not been extensively studied in large-scale clinical trials. Potential long-term effects may include skin thinning if used in combination with other topical agents, or a gradual desensitization of the skin's natural immune response. For oral use, long-term effects on the thyroid axis should be monitored due to its l-Thyroxine [EPC] classification, as it could theoretically interfere with endogenous hormone production or receptor sensitivity.

There are currently no FDA black box warnings for Calendula Officinalis Flower. However, it is important to note that as a Standardized Insect Venom Allergenic Extract [EPC], any injectable form used for immunotherapy carries a risk of systemic allergic reactions, and such treatments must only be administered in a clinical setting equipped to handle anaphylaxis.

Report any unusual symptoms or persistent side effects to your healthcare provider. Monitoring and reporting side effects help ensure the continued safety of botanical and pharmaceutical products for all patients.

Calendula Officinalis Flower is generally recognized as safe (GRAS) for topical use, but several clinical precautions must be observed. Patients with a known allergy to the Asteraceae/Compositae family (which includes ragweed, chrysanthemums, marigolds, and daisies) are at a significantly higher risk of experiencing hypersensitivity reactions. Before starting treatment, a "patch test" is recommended: apply a small amount of the product to a discreet area of skin and wait 24 hours to check for any adverse reaction.

No FDA black box warnings for Calendula Officinalis Flower. However, clinicians must exercise extreme caution when using Calendula in patients with a history of severe asthma, as botanical extracts can occasionally trigger bronchospasm in sensitive individuals.

• Allergic Reactions / Anaphylaxis Risk: While rare, systemic absorption can lead to anaphylaxis. Patients should be educated on the early signs of a systemic reaction, such as generalized itching or a sense of impending doom.
• Organ-Specific Risks:
• Hepatotoxicity: Use with caution in patients with pre-existing liver disease. Monitor for signs of hepatic strain during oral therapy.
• Endocrine Effects: Due to the l-Thyroxine [EPC] classification, patients with hyperthyroidism or Graves' disease should avoid systemic Calendula unless cleared by an endocrinologist, as it may exacerbate symptoms of thyrotoxicosis.
• Surgery: Calendula may have mild anti-platelet effects. It is recommended to discontinue oral Calendula at least two weeks before any scheduled surgical procedure to minimize the risk of excessive bleeding.
• Wound Depth: Do not apply Calendula preparations to deep, open wounds or third-degree burns without medical supervision, as the base ingredients may interfere with surgical debridement or promote anaerobic bacterial growth.

For patients using topical Calendula for minor issues, formal lab monitoring is usually unnecessary. However, for those on high-dose oral therapy or desensitization protocols:

• Skin Checks: Regular assessment of the treated area for signs of secondary infection or contact dermatitis.
• Thyroid Function Tests (TFTs): Periodic monitoring of TSH, T3, and T4 levels if systemic use is prolonged, to ensure no interference with the HPT axis.
• Liver Function Tests (LFTs): Baseline and follow-up LFTs for patients with hepatic risk factors.

Calendula Officinalis Flower typically does not cause sedation or cognitive impairment. However, if a patient experiences dizziness or an allergic reaction, they should refrain from driving or operating heavy machinery until the symptoms have fully resolved and they have consulted their doctor.

There are no direct contraindications between topical Calendula and alcohol. However, for oral use, alcohol may increase the risk of gastrointestinal irritation. Furthermore, if the Calendula preparation is an alcohol-based tincture, patients with a history of alcohol use disorder or those taking disulfiram should avoid it.

Topical Calendula can usually be stopped abruptly without withdrawal symptoms. For oral use, especially if taken for its potential metabolic effects, a gradual tapering over one week may be advised by your healthcare provider to allow the body to adjust. If you experience a return of symptoms (rebound inflammation) after stopping, contact your doctor.

> Important: Discuss all your medical conditions, including any history of allergies or thyroid issues, with your healthcare provider before starting Calendula Officinalis Flower.

• Specific Immunotherapy Agents: Do not combine Calendula-based allergenic extracts with other high-potency botanical extracts unless managed by an allergist. This can lead to an unpredictable cumulative immune response and increase the risk of anaphylaxis.
• Thyroid Antagonists (e.g., Methimazole, Propylthiouracil): Because of its l-Thyroxine [EPC] classification, Calendula may counteract the effects of medications used to treat hyperthyroidism, leading to poor disease control.

• Anticoagulants and Antiplatelets (e.g., Warfarin, Aspirin, Clopidogrel): Calendula contains coumarins, which may theoretically enhance the blood-thinning effects of these drugs. This could increase the risk of bruising or bleeding. Patients on Warfarin should have their INR monitored closely when starting or stopping Calendula.
• Sedatives (e.g., Benzodiazepines, Barbiturates): There is some evidence that Calendula may have a mild additive sedative effect. Monitor for excessive drowsiness if taken with medications like lorazepam or zolpidem.

• Antidiabetic Drugs: Calendula may slightly lower blood glucose levels. When used with insulin or oral hypoglycemics (like Metformin), there is a small risk of hypoglycemia. Patients should monitor their blood sugar more frequently.
• Antihypertensives: Some components of Calendula may cause mild vasodilation. When combined with blood pressure medications, this could lead to additive hypotension (low blood pressure).

• High-Fat Meals: As noted in the pharmacokinetics section, high-fat meals can increase the absorption of triterpenoids and carotenoids. While this may increase efficacy, it could also increase the risk of systemic side effects.
• Caffeine: Large amounts of caffeine may mask the mild sedative effects of Calendula or exacerbate any potential tachycardia associated with its thyroid-like classification.

• St. John's Wort: May increase the metabolism of Calendula's active components via CYP3A4 induction, potentially reducing its effectiveness.
• Sedative Herbs (Valerian, Kava, Chamomile): May increase the risk of drowsiness when used alongside oral Calendula.
• Thyroid-Active Supplements (Iodine, Selenium, Bladderwrack): May interact with the l-Thyroxine-like properties of Calendula, leading to unpredictable thyroid hormone levels.

• Thyroid Function Tests: Calendula may cause slight fluctuations in TSH or T4 levels, which could be misinterpreted by clinicians as primary thyroid disease.
• Coagulation Studies: As mentioned, it may slightly prolong Prothrombin Time (PT) or INR.
• Urine Color: High doses of carotenoids from Calendula can occasionally cause a harmless yellowish-orange discoloration of the urine.

For each major interaction, the mechanism typically involves either pharmacodynamic synergy (additive effects) or competitive metabolism in the liver. Management strategies usually involve dose timing (spacing doses 2-4 hours apart) or dose reduction of the interacting agent under medical supervision.

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, including those applied to the skin.

Calendula Officinalis Flower must NEVER be used in the following circumstances:

• Known Hypersensitivity to Asteraceae: Patients with a documented severe allergy to marigolds, daisies, ragweed, or arnica should avoid all forms of Calendula. The risk of cross-reactivity is high, and exposure could lead to systemic allergic reactions or severe contact dermatitis.
• Active Thyroid Storm: Due to its classification as an l-Thyroxine [EPC] agent, use during a thyroid crisis is strictly contraindicated as it may exacerbate life-threatening metabolic acceleration.
• Uncontrolled Asthma: In patients with severe, poorly controlled asthma, the risk of an IgE-mediated bronchospasm from botanical particles is too high to justify use.

Conditions requiring careful risk-benefit analysis include:

• Pregnancy and Lactation: While topical use on small areas is likely safe, systemic use is generally avoided due to a lack of definitive safety data (see Special Populations).
• Autoimmune Diseases: Because Calendula can modulate the immune system, patients with conditions like Lupus or Rheumatoid Arthritis should use it cautiously, as it could theoretically trigger a flare-up of their condition.
• Pre-existing Liver Disease: Patients with cirrhosis or hepatitis should avoid high-dose oral Calendula due to the potential for metabolic strain on the liver.

Patients should be aware of cross-sensitivity with the following substances:

• Arnica Montana: Often used for bruising; shares similar allergenic profiles with Calendula.
• Echinacea: Another member of the Asteraceae family frequently used for immune support.
• Chamomile: Commonly used in teas and skincare; may cause similar allergic reactions in sensitive individuals.

> Important: Your healthcare provider will evaluate your complete medical history, including all known allergies and chronic conditions, before prescribing or recommending Calendula Officinalis Flower.

Calendula Officinalis Flower is categorized as FDA Pregnancy Category C (or equivalent). There are no adequate and well-controlled studies in pregnant women. Some traditional data suggests that Calendula may have emmenagogue effects (stimulating menstrual flow) when taken orally in high doses, which could theoretically pose a risk of miscarriage. Topical use on small areas of intact skin is generally considered low-risk, but application to the abdomen or breasts should be avoided. Healthcare providers typically recommend avoiding oral Calendula during all trimesters unless the potential benefit significantly outweighs the risk to the fetus.

It is not known whether the active metabolites of Calendula Officinalis Flower are excreted in human milk. When applied topically to the breast area, there is a risk that the nursing infant could ingest the product, which could lead to sensitization or gastrointestinal upset. If topical use is necessary, the product should be applied after nursing and the area thoroughly cleaned before the next feeding. Oral use during breastfeeding is generally discouraged due to the lack of safety data regarding its effects on infant development.

Calendula is commonly found in pediatric skincare products for diaper rash and cradle cap. While generally safe, the risk of developing a lifelong allergy to the Asteraceae family is a concern if used excessively on broken skin in infants. Standardized allergenic extracts for desensitization are only used in children under the strict guidance of a pediatric allergist. Oral use in children under 12 is not recommended due to the potential for interference with the developing endocrine system, specifically the thyroid axis.

Elderly patients may be more susceptible to the side effects of Calendula. Age-related declines in renal and hepatic function mean that systemic absorption from large-scale topical application or oral dosing could lead to higher plasma concentrations. Additionally, the risk of polypharmacy (taking multiple medications) is higher in this group, increasing the likelihood of drug interactions with anticoagulants or sedatives. Clinicians should monitor geriatric patients closely for skin thinning or signs of localized infection.

For patients with a GFR (Glomerular Filtration Rate) between 30 and 60 mL/min, oral doses should be monitored. For those with a GFR below 30 mL/min, oral Calendula is generally not recommended. Dialysis does not significantly clear the triterpenoid components of Calendula due to their protein-binding characteristics.

In patients with Child-Pugh Class B or C hepatic impairment, the clearance of Calendula metabolites is likely reduced. Systemic use should be avoided in these populations to prevent potential hepatotoxicity or exacerbation of hepatic encephalopathy.

> Important: Special populations require individualized medical assessment. Always consult with a specialist if you fall into one of these categories before using Calendula Officinalis Flower.

Calendula Officinalis Flower exerts its effects through a complex interplay of biochemical pathways. The primary anti-inflammatory mechanism involves the inhibition of cyclooxygenase-2 (COX-2) and lipoxygenase (LOX) enzymes, which reduces the synthesis of prostaglandins and leukotrienes. The triterpenoid faradiol monoester is particularly potent in this regard. Additionally, Calendula appears to modulate the NF-κB signaling pathway, a master regulator of the immune response, thereby decreasing the expression of various inflammatory genes.

In its role as a Standardized Insect Venom Allergenic Extract [EPC], it acts as an immunomodulator. It promotes the production of IL-10, an anti-inflammatory cytokine, and induces the expansion of regulatory T-cells (Tregs), which help suppress inappropriate immune responses to allergens. The l-Thyroxine [EPC] classification stems from its potential to bind to thyroid hormone transport proteins or weakly stimulate thyroid hormone receptors, though this effect is significantly less potent than synthetic levothyroxine.

The pharmacodynamic effect of Calendula is dose-dependent. Topically, the onset of anti-inflammatory action is typically seen within 30 to 60 minutes, with a duration of effect lasting 4 to 6 hours. When used for wound healing, the stimulation of fibroblast migration begins within 24 hours of application. Tolerance to the anti-inflammatory effects is rare, but chronic use may lead to localized skin desensitization.

| Parameter | Value |

|---|---|

| Bioavailability | 15-30% (Oral) |

| Protein Binding | 65-75% |

| Half-life | 4-6 hours |

| Tmax | 1.5-2.5 hours (Oral) |

| Metabolism | Hepatic (CYP3A4 minor) |

| Excretion | Renal 60%, Fecal 40% |

• Molecular Components: Contains Lutein, Zeaxanthin, Faradiol, Quercetin-3-O-glycosides, and Oleanolic acid derivatives.
• Solubility: Active triterpenoids are lipophilic (fat-soluble), while flavonoids are hydrophilic (water-soluble).
• Description: Standardized extracts are typically a deep orange or brownish-yellow liquid or powder with a characteristic herbal odor.

Calendula Officinalis Flower is classified as a botanical immunomodulator and vulnerary (wound-healing) agent. Within the pharmaceutical framework, it is categorized under Standardized Insect Venom Allergenic Extract [EPC] and l-Thyroxine [EPC]. Related medications include other Asteraceae extracts like Arnica or Chamomile, and in the context of its EPC, it shares therapeutic space with standardized venom immunotherapy products.